Biotechnology
New patent for Galderma Labs drug EPSOLAY – DrugPatentWatch
Copyright © DrugPatentWatch. Originally published in New patent for Galderma Labs drug EPSOLAY
Annual Drug Patent Expiration for EPSOLAY
Epsolay is a drug marketed by Galderma Labs Lp and is included in one NDA. It is available from a single supplier. There are five patents protecting this drug.
This drug has twenty-eight patent family members in eleven countries.
The generic material in EPSOLAY is benzoyl peroxide. One registered supplier for this compound. Additional details are available on the benzoyl peroxide profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
Make Better Decisions with DrugPatentWatch
» Start Your Free Trial Today «
Copyright © DrugPatentWatch. Originally published in New patent for Galderma Labs drug EPSOLAY
